Tolerability and platelet fibrinogen receptor occupancy (FRO) after oral treatment with bibu-104-xx in healthy-volunteers [abstract] - Narjes,H.; Weisenberger,H.; Muller,T.H.; Deichsel,G.; Krause,J. (Thromb Haemost, 1995)